Overview

• The Office of the U.S. Trade Representative, led by Jamieson Greer, will open public consultations by Oct. 4 to begin the pact’s six-year review.
• The expected timetable includes a U.S. congressional hearing in January 2026 and a trilateral review meeting on July 1, 2026.
• The administration is treating effective anti-drug collaboration as a prerequisite for any more expansive commercial deal, according to the Wall Street Journal.
• U.S. 25% tariffs on non‑T‑MEC imports and on steel and aluminum, imposed in March, remain a key source of leverage in the talks.
• The U.S. has delivered a 57‑item list of alleged trade barriers to Mexico, while Mexican and Canadian officials report active engagement and early signs of progress.